Method of treating proteinuria in pregnancy
First Claim
1. A method for treating an individual exhibiting pregnancy-related elevated proteinuria, the method comprising administering to the individual a therapeutically effective amount of a pharmaceutical preparation comprising digestive enzymes, wherein the digestive enzymes comprise an amylase, a lipase, a protease, or a combination thereof, whereby pregnancy-related elevated proteinuria is treated.
2 Assignments
0 Petitions
Accused Products
Abstract
A therapeutic agent for the treatment of toxemia, preeclampsia and eclampsia and a method for preparing the therapeutic agent are disclosed. The therapeutic agent is a stable pharmaceutical preparation containing, but not limited to, digestive/pancreatic enzymes. The therapeutic agent may be manufactured by a variety of encapsulation technologies. Delivery of the therapeutic agent may be made orally, through injection, by adherence of a medicated patch or by other methods. Further, a method of using the presence of chymotrypsin in the maternal GI tract as a biomarker, to determine the likelihood of developing preeclampsia, a pregnancy induced hypertension, and eclampsia/toxemia is disclosed.
-
Citations
14 Claims
- 1. A method for treating an individual exhibiting pregnancy-related elevated proteinuria, the method comprising administering to the individual a therapeutically effective amount of a pharmaceutical preparation comprising digestive enzymes, wherein the digestive enzymes comprise an amylase, a lipase, a protease, or a combination thereof, whereby pregnancy-related elevated proteinuria is treated.
Specification